The

drugs

industry closed the day down 2%.

Tibet Pharmaceuticals Inc

(

TBET

),

Momenta Pharmaceuticals Inc

(

MNTA

),

Cardium Therapeutics Inc

(

CXM

), and

Pacific Biosciences of California Inc

(

PACB

) were all decliners today within the drugs industry with

Teva Pharmaceutical Industries

(

TEVA

) being today's featured drugs loser. Teva Pharmaceutical Industries fell 42 cents (-1.1%) to $39.11 on light volume. Throughout the day, four million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 6.6 million shares.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. Teva Pharmaceutical Industries has a market cap of $34.9 billion and is part of the

health care

sector. The company has a P/E ratio of 8.3, below the average drugs industry P/E ratio of 11.3 and below the S&P 500 P/E ratio of 17.7. Shares are down 24.9% year to date as of the close of trading on Monday.

TheStreet Ratings rates Teva as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and a generally disappointing performance in the stock itself.

On the positive front,

CEL-SCI Corporation

(

CVM

),

China Biologic Products Inc

(

CBPO

),

Idera Pharmaceuticals Inc

(

IDRA

), and

Cyclacel Pharmaceuticals Inc

(

CYCC

) were all gainers within the drugs industry with

Illumina Inc

(

ILMN

) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider

SPDR S&P Pharmaceuticals ETF

(

XPH

) while those bearish on the drugs industry could consider

ProShares UltraShort Nasdaq Biotech

(

BIS

).

null